Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$2.45 - $5.04 $160,230 - $329,616
-65,400 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$4.5 - $11.91 $98,100 - $259,638
21,800 Added 50.0%
65,400 $313,000
Q3 2021

Nov 16, 2021

BUY
$8.52 - $24.77 $371,472 - $1.08 Million
43,600 New
43,600 $404,000

Others Institutions Holding NRXP

About NRX Pharmaceuticals, Inc.


  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $111M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.